Navidea Biopharmaceuticals Inc (NAVB)
0.04
0.00 (0.00%)
USD |
OTCM |
Apr 26, 10:47
Navidea Biopharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2022 | -570.9K% |
September 30, 2022 | -75.94K% |
June 30, 2022 | -46.01K% |
March 31, 2022 | |
December 31, 2021 | -384.4K% |
September 30, 2021 | -26.74K% |
June 30, 2021 | -20.47K% |
March 31, 2021 | -13.19K% |
December 31, 2020 | -3.22K% |
September 30, 2020 | -42.81K% |
June 30, 2020 | -26.07K% |
March 31, 2020 | -17.57K% |
December 31, 2019 | -103.4K% |
September 30, 2019 | -62.80K% |
June 30, 2019 | -16.82K% |
March 31, 2019 | -77.11K% |
December 31, 2018 | -9.02K% |
September 30, 2018 | -17.13K% |
June 30, 2018 | -905.6% |
March 31, 2018 | -847.5K% |
December 31, 2017 | -44.47K% |
September 30, 2017 | |
June 30, 2017 | -5.19K% |
March 31, 2017 | |
December 31, 2016 |
Date | Value |
---|---|
September 30, 2016 | -3.26% |
June 30, 2016 | -572.4% |
March 31, 2016 | -388.6% |
December 31, 2015 | 32.17% |
September 30, 2015 | -202.8% |
June 30, 2015 | -337.9% |
March 31, 2015 | -345.8% |
December 31, 2014 | -312.3% |
September 30, 2014 | -306.6% |
June 30, 2014 | -951.2% |
March 31, 2014 | -1.56K% |
December 31, 2013 | -2.57K% |
September 30, 2013 | -2.82K% |
June 30, 2013 | -5.27K% |
March 31, 2013 | |
December 31, 2012 | -106.3K% |
September 30, 2012 | |
June 30, 2012 | -9.72K% |
March 31, 2012 | -58.58K% |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 | -35.68K% |
March 31, 2011 | -1.32K% |
December 31, 2010 | -438.9% |
September 30, 2010 | -1.59K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-570.9K%
Minimum
Dec 2022
-3.22K%
Maximum
Dec 2020
-100.7K%
Average
-34.77K%
Median
Profit Margin (Quarterly) Benchmarks
Perspective Therapeutics Inc | -- |
Electromed Inc | 12.23% |
Xtant Medical Holdings Inc | -15.31% |
Asensus Surgical Inc | -317.3% |
Senseonics Holdings Inc | -214.1% |